You are viewing the site in preview mode

Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Optimal empiric treatment for KPC-2-producing Klebsiella pneumoniae infections in critically ill patients with normal or decreased renal function using Monte Carlo simulation

Fig. 2

The MIC distribution of FOS in monotherapy or combination with TGC or CMS against 136 KPC-producing. Klebsiella pneumoniae, and probability of target attainment (PTA) of 24 AUC24/MIC for FOS dosing regimens in critically. Ill elderly patients with normal renal function (Left) and renal impairment (right). The dotted line indicates the PTA of 0.9. FOS, fosfomycin; TGC, tigecycline; CST, colistin

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us